SSSumito Saeki

Sumito Saeki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sumito Saeki has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Serial single-cell RNA sequencing unveils drug resistance and metastatic traits in stage IV breast cancer

    by Kazutaka Otsuji, Yoko Takahashi, Tomo Osako, Takayuki Kobayashi, Toshimi Takano, Sumito Saeki, Liying Yang, Satoko Baba, Kohei Kumegawa, Hiromu Suzuki, et al.

    Metastasis is a complex process that remains poorly understood at the molecular levels. We profiled single-cell transcriptomic, genomic, and epigenomic changes associated with cancer cell progression, chemotherapy resistance, and metastasis from a Stage IV breast cancer patient. Pretreatment- and posttreatment-specimens from the primary tumor and distant metastases were collected for single-cell RNA sequencing and subsequent cell clustering, copy number variation (CNV) estimation, transcriptomic factor estimation, and pseudotime analyses. CNV analysis revealed that a small population of pretreatment cancer cells resisted chemotherapy and expanded. New clones including Metastatic Precursor Cells (MPCs), emerged in the posttreatment primary tumors in CNV similar to metastatic cells. MPCs exhibited expression profiles indicative of epithelial–mesenchymal transition. Comparison of MPCs with metastatic cancer cells also revealed dynamic changes in transcription factors and calcitonin pathway gene expression. These findings demonstrate the utility of single-patient clinical sample analysis for understanding tumor drug resistance, regrowth, and metastasis.


  • Open Access

    Correction: Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives

    by Sumito Saeki, Tsuguo Iwatani, Atsuko Kitano, Naomi Sakurai, Yuko Tanabe, Chikako Yamauchi, Ataru Igarashi, Yusuke Kajimoto, Sayaka Kuba, Fumikata Hara, et al.


  • Open Access

    Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives

    by Sumito Saeki, Tsuguo Iwatani, Atsuko Kitano, Naomi Sakurai, Yuko Tanabe, Chikako Yamauchi, Ataru Igarashi, Yusuke Kajimoto, Sayaka Kuba, Fumikata Hara, et al.

    Background: Financial toxicity (FT) is a notable concern for patients with breast cancer worldwide. The situation regarding FT in Japan, however, has not been well explored. This study examined FT in patients with breast cancer in Japan and presented an overview of the group study’s overall findings. Methods: The survey used the Questant application and primarily targeted patients with breast cancer attending research facilities and physicians who are members of the Japanese Breast Cancer Society. The Japanese version of the Comprehensive Score for FT (COST) was used to quantify patients’ FT. Multiple regression analysis was used to identify factors related to FT in patients with breast cancer in Japan and evaluate the sufficiency of information support level (ISL) for medical expenses. Results: We collected 1558 responses from patients and 825 from physicians. In terms of factors affecting FT, recent payments had the highest impact, followed by stage, and related departments positively affecting FT. Conversely, factors such as income, age, and family support were found to negatively affect FT. A significant discrepancy was identified between patients and physicians in perceived information support, with patients frequently feeling unsupported and physicians believing that they have provided adequate support. Furthermore, differences in the frequency of explanations and opportunities to ask questions about medical costs across FT grades were found. The analysis also showed that physicians with a better understanding of information support needs and greater knowledge of medical costs tended to provide more support that is comprehensive. Conclusion: This study emphasizes the importance of addressing FT in patients with breast cancer in Japan and highlights the need for enhanced information support, deeper understanding by physicians, and collaborative efforts among professionals to mitigate financial burden and provide personalized, tailored support for individual needs.


  • Open Access

    Factors Associated with Financial Toxicity in Patients with Breast Cancer in Japan: A Comparison of Patient and Physician Perspectives

    by Sumito Saeki, Tsuguo Iwatani, Atsuko Kitano, Naomi Sakurai, Yuko Tanabe, Chikako Yamauchi, Ataru Igarashi, Yusuke Kajimoto, Sayaka Kuba, Fumikata Hara, et al.

    Background Patients with breast cancer are generally younger than those with other types of cancer. Their treatment often lasts for longer period, leading to increased costs and indirect burdens such as managing adverse events. Financial toxicity (FT) is a significant concern for patients with breast cancer worldwide, and the lack of medical cost information support in the United States is a notable issue. However, the situation regarding FT in Japan has not been well explored. Parallel with other related studies, this study aimed to examine FT in patients with breast cancer in Japan and present an overview of the group study’s overall findings.Methods The survey utilized the Questant application and primarily targeted patients with breast cancer attending research facilities and physicians who are Japanese Breast Cancer Society members. The Japanese version of the Comprehensive Score for FT (COST) was used to quantify patients’ FT. Multiple regression analysis was used to identify factors related to FT in patients with breast cancer in Japan and evaluate the sufficiency of information support level (ISL) for medical expenses.Results We collected 1,558 responses from patients and 825 from physicians. The results showed that recent payment was the most significant factor affecting patients’ FT. Furthermore, inadequate ISL by physicians was found, with ISL tending to decrease as FT increased. Regional differences in patients’ ISL were also identified. Physicians with a better understanding of information support needs and adequate knowledge of medical costs tended to provide more comprehensive support.Conclusion This study emphasizes the importance of addressing FT in patients with breast cancer in Japan and highlights the need for enhanced information support, deeper understanding by physicians, and collaborative efforts among professionals to mitigate financial burden and provide personalized, tailored support for individual needs.